166
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

A pilot screening study for low bone mass in Singaporean women using years since menopause and BMI

ORCID Icon, ORCID Icon, , , & ORCID Icon
Pages 163-169 | Received 12 Jan 2021, Accepted 20 Mar 2021, Published online: 30 Apr 2021

References

  • Kanis JA, McCloskey EV, Johansson H, et al. Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the Committee of Scientific Advisors of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019;30(1):3–44.
  • Eastell R, O’Neill TW, Hofbauer LC, et al. Postmenopausal osteoporosis. Nat Rev Dis Primers. 2016;2:16069.
  • Riggs BL, Khosla S, Melton LJ 3rd. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002;23(3):279–302.
  • World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group [meeting held in Rome from 22 to 25 June 1992]. Geneva: World Health Organization; 1994. (Report No.: 9241208430.
  • Chin KY. A review on the performance of osteoporosis self-assessment tool for Asians in determining osteoporosis and fracture risk. Postgrad Med. 2017;129(7):734–746.
  • Curry SJ, Krist AH, Owens DK, et al. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;319(24):2521–2531.
  • Ministry of Health Singapore. Osteoporosis — identification and management in primary care; 2018. Available from: https://www.ace-hta.gov.sg/healthcare-professionals/details/osteoporosis-identification-and-management-in-primary-care.
  • Koh LK, Sedrine WB, Torralba TP, et al. A simple tool to identify Asian women at increased risk of osteoporosis. Osteoporos Int. 2001;12(8):699–705.
  • Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007;18(8):1033–1046.
  • Subramaniam S, Chan C-Y, Soelaiman I-N, et al. The performance of osteoporosis self-assessment tool for Asians (OSTA) in identifying the risk of osteoporosis among Malaysian population aged 40 years and above. Arch Osteoporos. 2019;14(1):117.
  • Geater S, Leelawattana R, Geater A. Validation of the OSTA index for discriminating between high and low probability of femoral neck and lumbar spine osteoporosis among Thai postmenopausal women. J Med Assoc Thai. 2004;87(11):1286–1292.
  • Muslim D, Mohd E, Sallehudin A, et al. Performance of Osteoporosis Self-assessment Tool for Asian (OSTA) for Primary Osteoporosis in Post-menopausal Malay Women. Malays Orthop J. 2012;6(1):35–39.
  • Huang JY, Song WZ, Zeng HR, et al. Performance of the Osteoporosis Self-Assessment Tool for Asians (OSTA) in screening osteoporosis among middle-aged and old women in the Chengdu Region of China. J Clin Densitom. 2015;18(4):539–545.
  • Chan SP, Teo CC, Ng SA, et al. Validation of various osteoporosis risk indices in elderly Chinese females in Singapore. Osteoporos Int. 2006;17(8):1182–1188.
  • Chandran M, Chin YA, Choo KS, et al. 2020. Comparison of the osteoporosis Self-Assessment Tool for Asians and Fracture risk assessment tool – FRAX to identify densitometric defined osteoporosis: A discriminatory value analysis in a multi-ethnic female population in Southeast Asia. Osteoporos Sarcopenia. 2020;6(2):53–58.
  • Marques A, Ferreira RJ, Santos E, et al. The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1958–1967.
  • Hawker G, Mendel A, Lam MA, et al. A clinical decision rule to enhance targeted bone mineral density testing in healthy mid-life women. Osteoporos Int. 2012;23(7):1931–1938.
  • Subramaniam S, Chan C-Y, Soelaiman IN, et al. Development of osteoporosis screening algorithm for population aged 50 years and above in Klang Valley, Malaysia. Int J Environ Res Public Health. 2020;17(7):2526.
  • Panichyawat N, Tanmahasamut P. Comparison of OSTA index and KKOS scoring system for prediction of osteoporosis in postmenopausal women who attended Siriraj Menopause Clinic. J Med Assoc Thai. 2012;95(11):1365–1371.
  • Oh SM, Nam BH, Rhee Y, et al. Development and validation of osteoporosis risk-assessment model for Korean postmenopausal women. J Bone Miner Metab. 2013;31(4):423–432.
  • Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387–395.
  • University of Sheffield. FRAX Fracture Risk Assessment Tool UK2020. Available from: https://www.sheffield.ac.uk/FRAX/
  • De Laet C, Kanis JA, Odén A, et al. Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int. 2005;16(11):1330–1338.
  • Ribot C, Tremollieres F, Pouilles JM, et al. Obesity and postmenopausal bone loss: the influence of obesity on vertebral density and bone turnover in postmenopausal women. Bone. 1987;8(6):327–331.
  • Fassio A, Idolazzi L, Rossini M, et al. The obesity paradox and osteoporosis. Eat Weight Disord. 2018;23(3):293–302.
  • Greendale GA, Sowers M, Han W, Huang MH, et al. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN). J Bone Miner Res. 2012;27(1):111–118.
  • Bjørnerem Å, Wang X, Bui M, et al. Menopause-related appendicular bone loss is mainly cortical and results in increased cortical porosity. J Bone Miner Res. 2018;33(4):598–605.
  • Hedlund LR, Gallagher JC. The effect of age and menopause on bone mineral density of the proximal femur. J Bone Miner Res. 1989;4(4):639–642.
  • Siris ES, Chen YT, Abbott TA, Barrett-Connor E, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164(10):1108–1112.
  • Karaguzel G, Holick MF. Diagnosis and treatment of osteopenia. Rev Endocr Metab Disord. 2010;11(4):237–251.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.